Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Resverlogix Corp T.RVX

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  RVXCF

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing small molecules that selectively inhibit Bromodomain and ExtraTerminal domain (BET) proteins, a new and emerging target for high risk vascular diseases.
Price: $0.59 Volume: 45,105
Change: +$0.03 % Change: +5.36%
Day High/Low: 0.59/0.56 52 Week High/Low: 0.89/0.435
Last Traded: November 21, 2014 10:30 Transaction Volume: 135
Open: 0.57 Previous Close: 0.56
Bid: 0.57 Ask: 0.59
Bid Size: 12500 Ask Size: 5000
Market Cap: 50.3m Shares Out: 85.3m
PE Ratio: 2.3 Dividend Yield: N/A

Opinion

Blogger says 2014 may be a good year for Canadian Zinc (T.CZN)

Stockhouse Editorial   December 24, 2013
0 stars

Stockhouse Research: Sometimes no news is good news

Another day, another bullboard war. But not much else.

Chris Parry   September 10, 2013
0 stars

Stockhouse Research: The day Niko Resources came to play

Another day, another surprising block of Stockhouse user data.

Chris Parry   September 6, 2013
0 stars

Stockhouse Research: Resverlogix (T.RVX) and Colabor (T.GCL) sparking interest

Newcomers make the list on Stockhouse Research's roundup of what's hot on Stockhouse.com today.

Chris Parry   September 3, 2013
0 stars

Latest Bullboard Posts